Stock Market Today, Dec. 29: UiPath Edges Higher After Morgan Stanley Price Target Increase

UiPath closed at $16.85, up 0.06% on volume of 31.3M shares (about 15% above its three‑month average of 27.1M) following a Morgan Stanley upgrade of its price target from $15 to $19 while reiterating an Equal Weight rating. The company beat Q3 expectations in early December, has gained over 20% in the past month amid momentum around combining automation with agentic AI and announced partnerships with OpenAI, Snowflake and Nvidia; it will join the S&P MidCap 400 on Jan. 2, 2026. Despite these catalysts, the stock remains roughly 75% below its 2021 IPO level, leaving room for investor scrutiny on whether recent profitability marks sustainable AI‑driven growth.

Analysis

Market structure: UiPath (PATH) is positioned as a direct beneficiary of faster AI-driven automation adoption, with immediate winners being GPU providers (NVDA) and cloud/data infra (SNOW) that reduce integration friction; legacy/manual-process vendors lose pricing power as customers shift to agentic automation. Index inclusion (S&P MidCap 400 on Jan 2, 2026) creates a time-bound demand shock — expect concentrated buying in the 1–4 weeks leading to inclusion and potential reversion after rebalancing.

Risk assessment: Tail risks include failed enterprise adoption, an adverse OpenAI/API pricing change or GPU supply shocks that compress PATH gross margins; regulatory scrutiny of agentic AI could impose compliance costs. Near-term (days–weeks) risk is index-flow reversal and earnings guidance; medium-term (3–12 months) risk is margin dilution from expensive AI compute; long-term (1–3 years) hinges on sustainable ARR expansion and 20–30%+ gross margin retention.

Trade implications: Tactical trades should front-run index flows and hedge compute exposure — short-dated directional trades before Jan 2, 2026 and longer-dated exposure to capture adoption. Use defined-risk options to limit downside: cash-secured puts or buying OTM calls with 6–18 month tenors to capture asymmetric upside while capping loss.

Contrarian angles: The market underestimates cost-side pressure (OpenAI/Nvidia pricing) and overestimates durable pricing power from partnerships — the Morgan Stanley Equal Weight lift suggests limited fundamental surprise. Historical parallel: AI-hype rallies (e.g., C3.ai) produced sharp near-term spikes then multi-quarter mean reversion when monetization lagged; PATH could follow if bookings/gross margin miss after the inclusion pop.

Key Decisions for Investors

• Establish a tactical 2.0–3.0% long position in PATH within the next 7–10 trading days to capture S&P MidCap 400 inclusion flows (Jan 2, 2026); set a hard stop-loss at $14 (≈‑17% from $16.85) and trim 50% of the position at $24 (~+42%).
• Sell a 90-day cash-secured PUT on PATH at a $14 strike (or nearest available) size-equivalent to 1–2% portfolio exposure to collect premium and set a lower-cost entry; roll or convert to long if assigned.
• Buy 6–18 month OTM PATH calls (e.g., Jan 2027 LEAP or nearest 9–12 month expiries 20–30% OTM) sized to 0.5–1.0% portfolio to capture asymmetric upside from adoption without equity downside.
• Overweight NVDA by 1–2% (long) to hedge GPU/compute tailwinds and underweight/trim SNOW by 1% (short or reduce exposure) for a 3–6 month relative-value trade: long PATH + NVDA, reduced SNOW exposure to exploit re-rating potential and cost-pressure differentiation.